Table 5 Time interval between first consultancy and diagnosis and potential determinant (Univariate regression)
ICC/MOR | 95 % CI MOR | P-value | |||
|---|---|---|---|---|---|
Hospital random effect | 0.00 | ||||
Empty model | 1.00 | 1.00–1.00 | 1.000 | ||
Median (days) | IQR (days) | OR >100 days | 95 % CI OR | ||
Age | |||||
<65 years | 84.0 | 182.0 | 1 | ||
≥65 years | 91.0 | 105.5 | 0.96 | 0.64–1.43 | 0.830 |
BMI | |||||
<25 | 102.0 | 163.0 | 1 | ||
≥25 | 86.0 | 110.3 | 0.64 | 0.40–1.01 | 0.057 |
Education level | |||||
Primary education or lower | 90.5 | 108.5 | 1 | ||
Graduate school or higher | 86.0 | 139.0 | 1.00 | 0.69–1.45 | 0.992 |
ECOG WHO Score | |||||
Fully active | 87.5 | 126.8 | 1 | ||
Restrictive or worse | 95.0 | 129.0 | 1.18 | 0.76–1.83 | 0.474 |
Specialist first consultation | |||||
Primary care | 91.0 | 139.5 | 1 | ||
Hospital or specialist | 79.0 | 106.0 | 0.78 | 0.50–1.22 | 0.277 |
Primary tumour clinical stage (T) | |||||
T1a–T1c | 95.5 | 141.3 | 1 | ||
T2a–T4 | 85.0 | 108.5 | 0.73 | 0.50–1.07 | 0.110 |
PSA value | |||||
<10 | 95.0 | 135.5 | 1 | ||
≥10 | 84.0 | 108.5 | 0.81 | 0.54–1.21 | 0.310 |
Total Gleason score | |||||
<7 | 87.0 | 140.0 | 1 | ||
≥7 | 91.0 | 111.5 | 0.87 | 0.60–1.27 | 0.464 |
Symptoms | |||||
No symptoms or discomfort | 83.0 | 110.0 | 1 | ||
One or more symptoms | 110.0 | 174.0 | 1.93 | 1.29–2.89 | 0.001 |